Cargando…
Correction: Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111607/ http://dx.doi.org/10.1371/journal.pone.0103652 |
Ejemplares similares
-
Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis
por: Mei, Zu-Bing, et al.
Publicado: (2014) -
Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis
por: Zhou, Ping-Ting, et al.
Publicado: (2017) -
Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trials
Publicado: (2015) -
Correction: A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin
por: Geagea, Alice Gerges, et al.
Publicado: (2019) -
Correction: A systematic review and meta-analysis of the protective effects of metformin in experimental myocardial infarction
por: Hesen, Nienke A., et al.
Publicado: (2018)